260 related articles for article (PubMed ID: 29296801)
1. Pharmacotherapeutical strategies in the prevention of acute, vaso-occlusive pain in sickle cell disease: a systematic review.
Sins JWR; Mager DJ; Davis SCAT; Biemond BJ; Fijnvandraat K
Blood Adv; 2017 Aug; 1(19):1598-1616. PubMed ID: 29296801
[TBL] [Abstract][Full Text] [Related]
2. Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
Weaver SB; Rungkitwattanakul D; Singh D
J Pharm Pract; 2023 Feb; 36(1):139-148. PubMed ID: 34151636
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
Han J; Saraf SL; Gordeuk VR
Pharmacotherapy; 2020 Jun; 40(6):535-543. PubMed ID: 32350885
[TBL] [Abstract][Full Text] [Related]
5. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease.
Cieri-Hutcherson NE; Hutcherson TC; Conway-Habes EE; Burns BN; White NA
Pharmacotherapy; 2019 Nov; 39(11):1095-1104. PubMed ID: 31505045
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Emerging Therapies for the Management of Pain and Vaso-Occlusive Crises in Patients With Sickle Cell Disease: A Systematic Review of Randomized Controlled Trials.
Lowe M; Bambhroliya Z; Patel H; Patel VJ; Vudugula SA; Cheruvu NP; Raza S; Okunlola OI
Cureus; 2023 Apr; 15(4):e38014. PubMed ID: 37223201
[TBL] [Abstract][Full Text] [Related]
9. Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease.
Osunkwo I; Manwani D; Kanter J
Ther Adv Hematol; 2020; 11():2040620720955000. PubMed ID: 33062233
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review.
Dick MH; Abdelgadir A; Kulkarni VV; Akram H; Chatterjee A; Pokhrel S; Khan S
Cureus; 2022 May; 14(5):e24920. PubMed ID: 35706735
[TBL] [Abstract][Full Text] [Related]
11. The impact of Hydroxyurea on the rates of Vaso-occlusive crises in patients with sickle cell disease in Saudi Arabia: a single-center study.
Alkhalifah SA; Alanazi M; Almasaoud MA; Al-Malki HS; Al-Murdhi FM; Al-Hazzaa MS; Al-Mufarrij SM; Albabtain MA; Alshiakh AA; AlRuthia Y
BMC Emerg Med; 2022 Nov; 22(1):188. PubMed ID: 36447134
[TBL] [Abstract][Full Text] [Related]
12. Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis.
Kutlar A; Kanter J; Liles DK; Alvarez OA; Cançado RD; Friedrisch JR; Knight-Madden JM; Bruederle A; Shi M; Zhu Z; Ataga KI
Am J Hematol; 2019 Jan; 94(1):55-61. PubMed ID: 30295335
[TBL] [Abstract][Full Text] [Related]
13. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.
Udeze C; Evans KA; Yang Y; Lillehaugen T; Manjelievskaia J; Mujumdar U; Li N; Andemariam B
Adv Ther; 2023 Aug; 40(8):3543-3558. PubMed ID: 37332020
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of l-glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar's healthcare perspective.
Adel AM; Abushanab D; Al-Badriyeh D; Hamad A; Alshurafa A; Yassin MA
SAGE Open Med; 2024; 12():20503121231224551. PubMed ID: 38711465
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
Pittman DD; Hines PC; Beidler D; Rybin D; Frelinger AL; Michelson AD; Liu K; Gao X; White J; Zaidi AU; Charnigo RJ; Callaghan MU
Blood; 2021 Apr; 137(15):2010-2020. PubMed ID: 33067606
[TBL] [Abstract][Full Text] [Related]
16. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
[TBL] [Abstract][Full Text] [Related]
17. Neuropathic Pain in Children with Sickle Cell Disease: The Hidden Side of the Vaso-Occlusive Crisis.
Sigalla J; Duparc Alegria N; Le Roux E; Toumazi A; Thiollier AF; Holvoet L; Benkerrou M; Dugue S; Koehl B
Children (Basel); 2021 Jan; 8(2):. PubMed ID: 33530318
[TBL] [Abstract][Full Text] [Related]
18. Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.
Shah NR; Bhor M; Latremouille-Viau D; Kumar Sharma V; Puckrein GA; Gagnon-Sanschagrin P; Khare A; Kumar Singh M; Serra E; Davidson M; Xu L; Guerin A
J Med Econ; 2020 Nov; 23(11):1345-1355. PubMed ID: 32815766
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents for preventing vaso-occlusive events in people with sickle cell disease: a systematic review.
Martí-Carvajal A; Abd El Aziz MA; Martí-Amarista C; Solà I
Clin Adv Hematol Oncol; 2019 Apr; 17(4):234-243. PubMed ID: 31188815
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
